Literature DB >> 5710524

Developmental changes in monoamines of mouse brain.

H C Agrawal, S N Glisson, W A Himwich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5710524     DOI: 10.1016/0028-3908(68)90003-8

Source DB:  PubMed          Journal:  Int J Neuropharmacol        ISSN: 0375-9458


× No keyword cloud information.
  7 in total

1.  Cockayne syndrome B protects against methamphetamine-enhanced oxidative DNA damage in murine fetal brain and postnatal neurodevelopmental deficits.

Authors:  Gordon P McCallum; Andrea W Wong; Peter G Wells
Journal:  Antioxid Redox Signal       Date:  2011-01-05       Impact factor: 8.401

2.  Learning deficits in 4 weeks old offspring of the nursing mothers treated with the neuroleptic drug penfluridol.

Authors:  S Ahlenius; R Brown; J Engel; P Lundborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations.

Authors:  L Olson; A Seiger
Journal:  Z Anat Entwicklungsgesch       Date:  1972

4.  Ontogenetic development of locomotor activity and rate of tyrosine hydroxylation.

Authors:  P E Melberg; S Ahlenius; J Engel; P Lundborg
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

5.  Norepinephrine in fetal and neonatal rabbit brain.

Authors:  I Motelica-Heino; J Roffi
Journal:  Experientia       Date:  1975-10-15

6.  Oxoguanine glycosylase 1 protects against methamphetamine-enhanced fetal brain oxidative DNA damage and neurodevelopmental deficits.

Authors:  Andrea W Wong; Gordon P McCallum; Winnie Jeng; Peter G Wells
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

7.  Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.

Authors:  G R Breese; T D Traylor
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.